Velorum Therapeutics
United States
unknown
unknown
Stage
1
Investors
About
Velorum Therapeutics develops medicines that target the biology of heme to enable novel therapeutic approaches. The company focuses on biotech drug-discovery efforts with programs including oncology.
Explore Velorum Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.